Blossomhill Therapeutics, Inc. (BLSM)
13.94
-1.04
(-6.94%)
USD |
NASDAQ |
Oct 16, 16:00
14.03
+0.09
(+0.65%)
After-Hours: 20:00
Blossomhill Therapeutics Net Income (Quarterly) : -23.76M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.76M |
| March 31, 2026 | -21.01M |
| Date | Value |
|---|---|
| June 30, 2025 | -13.24M |
| March 31, 2025 | -10.48M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IGC Pharma, Inc. | -2.936M |
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 23.76M |
| EPS Diluted (Quarterly) | -0.7475 |
| Enterprise Value | 627.90M |
| Earnings Yield | -15.46% |
| Normalized Earnings Yield | -15.46 |